Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapies
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapies
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 42, Issue 7, Pages 889-901
Publisher
Wiley
Online
2015-08-07
DOI
10.1111/apt.13343
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tenofovir versus Entecavir in Treatment of Chronic Hepatitis B Virus with Severe Acute Exacerbation
- (2015) Chao-Hung Hung et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
- (2015) Michael Charlton et al. GASTROENTEROLOGY
- All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study
- (2015) David R. Nelson et al. HEPATOLOGY
- Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus-related cirrhosis
- (2015) Jeong Won Jang et al. HEPATOLOGY
- Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestry
- (2015) Peter J. Ruane et al. JOURNAL OF HEPATOLOGY
- Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting
- (2015) Christoph Höner zu Siederdissen et al. LIVER INTERNATIONAL
- Re-treatment of Chronic Hepatitis C Virus Genotype 1 Infection After Relapse
- (2014) Anu Osinusi et al. ANNALS OF INTERNAL MEDICINE
- Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters
- (2014) Adriaan J van der Meer et al. GUT
- Life Expectancy in Patients With Chronic HCV Infection and Cirrhosis Compared With a General Population
- (2014) Adriaan J. van der Meer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome
- (2014) Eric G. Meissner et al. JOURNAL OF CLINICAL INVESTIGATION
- Global epidemiology and genotype distribution of the hepatitis C virus infection
- (2014) Erin Gower et al. JOURNAL OF HEPATOLOGY
- Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study
- (2014) Eric Lawitz et al. LANCET
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
- (2014) Mark S. Sulkowski et al. NEW ENGLAND JOURNAL OF MEDICINE
- ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
- (2014) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- PEG-IFN Alpha but Not Ribavirin Alters NK Cell Phenotype and Function in Patients with Chronic Hepatitis C
- (2014) Antoaneta A. Markova et al. PLoS One
- Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevir
- (2013) B. Maasoumy et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
- (2013) Adriaan J. van der Meer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics
- (2013) Anuoluwapo Osinusi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C
- (2013) Thierry Poynard et al. JOURNAL OF HEPATOLOGY
- Impact of ribavirin priming on viral kinetics and treatment response in chronic hepatitis C genotype 1 infection
- (2013) U. Mihm et al. JOURNAL OF VIRAL HEPATITIS
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Is There a Role for Ribavirin in the Era of Hepatitis C Virus Direct-Acting Antivirals?
- (2012) Jordan J. Feld GASTROENTEROLOGY
- A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
- (2012) Roberta D'Ambrosio et al. HEPATOLOGY
- Management of alcoholic hepatitis
- (2012) Philippe Mathurin et al. JOURNAL OF HEPATOLOGY
- Outcome of sustained virological responders with histologically advanced chronic hepatitis C
- (2010) Timothy R. Morgan et al. HEPATOLOGY
- Diagnosis and management of autoimmune hepatitis
- (2010) Michael P. Manns et al. HEPATOLOGY
- Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B
- (2010) Vincent Wai-Sun Wong et al. JOURNAL OF HEPATOLOGY
- Eradication of Hepatitis C Virus in Patients Successfully Treated for Chronic Hepatitis C
- (2008) Sarah Maylin et al. GASTROENTEROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started